Research from Public Assistance - Paris Hospitals (AP-HP) in the Area of Kinase Inhibitors Described (Physicochemical Stability Study of Oral Suspension Containing Ruxolitinib in Children with Steroid-Refractory Acute Graft-Versus-Host Disease)

MLA

“Research from Public Assistance - Paris Hospitals (AP-HP) in the Area of Kinase Inhibitors Described (Physicochemical Stability Study of Oral Suspension Containing Ruxolitinib in Children with Steroid-Refractory Acute Graft-Versus-Host Disease).” Obesity, Fitness & Wellness Week, June 2022, p. 3509. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.707615698&authtype=sso&custid=ns315887.

APA

Research from Public Assistance - Paris Hospitals (AP-HP) in the Area of Kinase Inhibitors Described (Physicochemical Stability Study of Oral Suspension Containing Ruxolitinib in Children with Steroid-Refractory Acute Graft-Versus-Host Disease). (2022, June 25). Obesity, Fitness & Wellness Week, 3509.

Chicago

Obesity, Fitness & Wellness Week. 2022. “Research from Public Assistance - Paris Hospitals (AP-HP) in the Area of Kinase Inhibitors Described (Physicochemical Stability Study of Oral Suspension Containing Ruxolitinib in Children with Steroid-Refractory Acute Graft-Versus-Host Disease),” June 25. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.707615698&authtype=sso&custid=ns315887.